These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6953997)

  • 21. Chronic renal failure in children treated with methyl CCNU.
    Harmon WE; Cohen HJ; Schneeberger EE; Grupe WE
    N Engl J Med; 1979 May; 300(21):1200-3. PubMed ID: 431647
    [No Abstract]   [Full Text] [Related]  

  • 22. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute nonlymphocytic leukemia associated with nitrosourea chemotherapy: report of two cases.
    Cohen RJ; Wiernik PH; Walker MD
    Cancer Treat Rep; 1976 Sep; 60(9):1257-61. PubMed ID: 1071015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.
    Shepard KV; Larson R; Le Beau MM; Leichman L; Levin B
    Invest New Drugs; 1988 Jun; 6(2):121-4. PubMed ID: 3170132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial pulmonary fibrosis as a complication of prolonged methyl-CCNU therapy.
    Lee W; Moore RP; Wampler GL
    Cancer Treat Rep; 1978 Sep; 62(9):1355-8. PubMed ID: 688278
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU.
    Fischetti MR; Carey RW; Weitzman SA; Kaufman S; Kelley RM; Sohier WD
    Med Pediatr Oncol; 1978; 4(3):277-8. PubMed ID: 683130
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicity of very high dose nitrosourea administration.
    Breeden JH; Vollmer JT; Twomey PL
    Cancer; 1982 Nov; 50(9):1728-33. PubMed ID: 7116300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU.
    Block M; Lachowiez RM; Rios C; Hirschl S
    Med Pediatr Oncol; 1990; 18(3):256-60. PubMed ID: 2329971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
    Micetich KC; Jensen-Akula M; Mandard JC; Fisher RI
    Am J Med; 1981 Dec; 71(6):967-72. PubMed ID: 7032289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
    Firat D; Tekuzman G
    Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-CCNU for patients with previously treated metastatic neuroblastoma--a phase II study.
    Evans AE; Bernstein I; Finklestein J; Klemperer M; Leikin S; Weiner JM; Hammond GD
    Cancer Treat Rep; 1977; 61(1):83-5. PubMed ID: 324623
    [No Abstract]   [Full Text] [Related]  

  • 34. Methyl-CCNU and ftorafur in treatment of rectosigmoidal tumors and ftorafur capsules in treatment of colorectal tumors.
    Mechl Z; Malír
    Recent Results Cancer Res; 1981; 79():59-64. PubMed ID: 6795699
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma.
    Berd D; Wilson EJ; Bellet RE; Mastrangelo MJ
    Cancer Res; 1979 Nov; 39(11):4472-6. PubMed ID: 387215
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorouracil, methyl-CCNU and vincristine in cancer of the colon.
    Falkson G; Falkson HC
    Cancer; 1976 Oct; 38(4):1468-70. PubMed ID: 791472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
    Cohen MH; Schoenfeld D; Wolter J
    Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
    Sordillo PP; Magill GB
    Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic colorectal cancer. Combination chemotherapy in patients previously treated with 5-fluorouracil.
    Moayeri H; DiBenedetto J; Mittelman A
    N Y State J Med; 1980 Jul; 80(8):1220-4. PubMed ID: 6931307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.